Skip to content
Wednesday, November 11, 2026
BoldDrive

Administering Pluripotent Cells in Utero to Babies with Spina Bifida Enhances Quality of Life, Trial Finds

An innovative clinical study has found that delivering regenerative cells to unborn babies affected by spina bifida while undergoing fetal surgery can be a "major milestone" in managing prenatal disorders.

Research Framework and Assurance

The US-based trial involved six fetuses with the 'open' form of spina bifida. Doctors administered mother's placental stem cells on the exposed area of the infant's spine while the defect was being closed.

Importantly, the cell therapy demonstrated a favorable safety profile. Doctors verified that the cells did not cause neoplasms, hinder surgical recovery, or impede the resolution of related neurological issues.

Encouraging Results

Post-birth MRI scans indicated a complete reversal of Chiari malformation in each of the babies. This brain structure normalization is strongly associated with improved motor skills and quality of life.

"Should it enable additional babies able to walk who wouldn't have, it may emerge as the conventional approach," commented the principal investigator. "The results are extremely promising and pave the way for a variety of prospective new treatments."

Future Implications and Hope

Independent medical specialists indicated that additional validation of these apparent benefits could signal a "different age" in prenatal intervention. The potential to improve nerve function impairment seen in utero is considered a transformative goal.

Notably important would be improvements in bladder and bowel function, which are common challenges for those diagnosed with this condition.

Future Directions

Despite this being a first-in-human effort focused on a handful of cases, its confirmed tolerability and hopeful trends offer a robust platform for expanded clinical research. The combination of regenerative medicine with established fetal surgery techniques offers substantial hope for improving the prognosis for infants diagnosed prenatally with this neural tube defect.

The writer

Rebecca Clark

Automotive journalist with over a decade of experience covering car technology and industry trends.

BoldDrive

Type to search articles.